See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2012_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 58,026,381 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 861,364 |
| 3 | remainder_Assets | 3,492,010 |
| 4 | LiabilitiesCurrent | 7,227,703 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 17,336,760 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,981,490 |
| 9 | ResearchAndDevelopmentExpense | 44,182,260 |
| 10 | remainder_Expenses | 879,813 |
| 11 | remainder_Revenues | 450,160 |
| 12 | remainder_NetIncome | -15,101 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 62,379,755 |
| 1 | Liabilities | 24,564,463 |
| 2 | Expenses | 52,043,563 |
| 3 | Revenues | 450,160 |
| 4 | StockholdersEquity | 37,815,292 |
| 5 | NetIncome | -51,608,504 |
| 6 | ComprehensiveNetIncome | -51,608,504 |
| 7 | BaseVar | 69,726,521 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.709 |
| 9 | EconomicCapitalRatio | 2.06 |
Edgar->Model Mapping
Feature Distribution
